General Research
Model: mouse
Nephroprotective effect of electrolyzed reduced water against cisplatin-induced kidney toxicity and oxidative damage in mice
Simplified Version Available
How Hydrogen-Rich Water May Help Protect Your Kidneys During Chemo
A study from Taiwan found that drinking hydrogen-rich water may help protect kidneys from damage caused by the chemo drug cisplatin. The water, which is rich in hydrogen, may reduce oxidative stress and help keep kidneys healthy. This is promising news for people undergoing chemotherapy.
Read Simplified ArticleAbstract
Publish Year 2018 Country Taiwan Rank Positive Journal Journal of the Chinese Medical Association Primary Topic Kidney Secondary TopicCancer Model Mouse Tertiary TopicChemotherapy Toxicity (Cisplatin) Vehicle Water (Electrolysis) pH Alkaline Application Ingestion Comparison Complement
Background
Methods: Animals were divided into four groups as follows: normal control group, cisplatin control group, ERW control group and ERW + cisplatin group. Each group comprised 10 animals, which were orally treated with normal saline or ERW daily companion by administration of one dose of cisplatin for 28 days. Animals in the cisplatin group received an intraperitoneal single-dose injection of cisplatin (20 mg/kg body weight) as a single i.p. dose on the 25th day of the experiment. We determined the hydration state in urine and the level of serum markers of kidney function, the levels of glutathione (GSH) and thiobarbituric acid-reactive substances (TBARS) levels and the activities of glutathione peroxidase (GPx), glutathione reductase (GR), catalase (CAT) and superoxidase dismutase (SOD) in kidney and histopathological changes.
Methods
Results: After administration of ERW, the reduced urinary osmolality was increased and elevated Na+, K+, Mg2+ and Ca2+ levels in urine were significantly decreased in cisplatin-induced renal injury mice. Besides, the results demonstrated that significantly decreased elevated serum levels of creatinine and blood urea nitrogen (BUN) and the levels of TBARS in the kidneys that were induced by cisplatin. Moreover, ERW treatment was also found to markedly increase (p < 0.05) the activities of GPx, GR, CAT and SOD, and to increase GSH content in the kidneys. Histopathology showed that ERW protects against cisplatin-induced renal injury to both the proximal and distal tubules.
Results
Conclusion: ERW exhibits potent nephroprotective effects on cisplatin-induced kidney damage in mice, likely due to both the increase in antioxidant-defense system activity and the inhibition of lipid peroxidation.